Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Total Debt (2021 - 2025)

Bioregenx (BRGX) has 5 years of Total Debt data on record, last reported at $181069.0 in Q3 2025.

  • For Q3 2025, Total Debt fell 91.09% year-over-year to $181069.0; the TTM value through Sep 2025 reached $181069.0, down 91.09%, while the annual FY2024 figure was $2.0 million, 124.33% up from the prior year.
  • Total Debt reached $181069.0 in Q3 2025 per BRGX's latest filing, down from $1.2 million in the prior quarter.
  • Across five years, Total Debt topped out at $2.0 million in Q3 2024 and bottomed at $150000.0 in Q1 2024.
  • Average Total Debt over 5 years is $744351.9, with a median of $200000.0 recorded in 2021.
  • Peak YoY movement for Total Debt: surged 916.6% in 2024, then crashed 91.09% in 2025.
  • A 5-year view of Total Debt shows it stood at $200000.0 in 2021, then changed by 0.0% to $200000.0 in 2022, then soared by 350.68% to $901362.0 in 2023, then skyrocketed by 124.33% to $2.0 million in 2024, then crashed by 91.05% to $181069.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Total Debt were $181069.0 in Q3 2025, $1.2 million in Q2 2025, and $1.1 million in Q1 2025.